Product information and disease descriptionPlace of product in therapyDisease description
Diagnosis
12 evidence topics · 9 sources
Guideline initial evaluation: history elements
| Element of the initial history | Quoted text |
|---|---|
| Symptom: distortion | “Metamorphopsia” |
| Symptom: reduced acuity | “Decreased vision” |
| Symptom: central field loss | “Scotoma” |
| Symptom: low-luminance function | “Difficulties in dark adaptation” |
| Family history | “Family history, especially family history of AMD” |
| Social history | “Social history, especially a quantitative smoking history” |
Guideline imaging: optical coherence tomography and OCT-based atrophy classification
Guideline position on genetic testing
Fundus autofluorescence: decreased signal over atrophy and regulatory acceptance as a trial endpoint
“FAF imaging provides high-contrast retinal images that are particularly valuable for the diagnosis and evaluation of GA as loss of RPE and fluorophores in atrophic areas is associated with a decreased FAF signal” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Of note, the FAF signal using blue light excitation is physiologically reduced in the central macula mainly due to signal absorbance by the macula pigments lutein and zeaxanthin” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Atrophy in these areas may therefore not be visible by blue light excitation FAF imaging. Hence, simultaneous OCT or NIR imaging is recommended, particularly in patients with suspected foveal involvement.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Fundus autofluorescence imaging is particularly useful for identifying and monitoring geographic atrophy progression, and regulatory authorities have accepted its application in clinical trials to assess the change in geographic atrophy lesion area as the primary outcome measure.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Consensus OCT definition of complete RPE and outer retinal atrophy
“OCT was proposed as the reference standard or base imaging method to diagnose and stage atrophy. Other methods, including fundus autofluorescence, near-infrared reflectance, and color imaging, provided complementary and confirmatory information.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Specific OCT criteria to diagnose cRORA were proposed: (1) a region of hypertransmission of at least 250 μm in diameter, (2) a zone of attenuation or disruption of the RPE of at least 250 μm in diameter, (3) evidence of overlying photoreceptor degeneration, and (4) absence of scrolled RPE or other signs of an RPE tear.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Features of photoreceptor degeneration include all of the following: loss of the interdigitation zone, ellipsoid zone, and external limiting membrane and thinning of the outer nuclear layer.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Consensus OCT definition of incomplete RPE and outer retinal atrophy
“In the context of drusen, iRORA is defined on OCT as (1) a region of signal hypertransmission into the choroid and (2) a corresponding zone of attenuation or disruption of the RPE, and (3) evidence of overlying photoreceptor degeneration. The term iRORA should not be used when there is an RPE tear. Longitudinal studies confirmed the concept of progression from iRORA to cRORA.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Consensus update: en face OCT for measuring complete RPE and outer retinal atrophy
“The CAM group affirmed the role of en face OCT as a critical adjunct to traditional B-scan analysis, for more precise measurement of the area of cRORA lesions and for distinguishing threshold cRORA from smaller incomplete retinal pigment epithelial and outer retinal atrophy lesions.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The consensus panel’s adoption of the abnormal RPE band term as a unified category for RPE abnormalities may reduce confusion regarding the definition of RPE degeneration and has the potential to improve interreader variability.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Expert panel recommendations: OCT as the preferred method and the role of fundus autofluorescence
“Panelists agreed that OCT was the preferred imaging method to identify GA because of both its ease of use and accessibility among optometrists and ophthalmologists.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“As disease progresses, OCT remains the primary imaging modality for GA identification because of the prominent, readily identifiable hypertransmission that occurs beyond atrophic lesions.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Fundus autofluorescence does not confer much additional information compared to what can be obtained from OCT (B-scan and en face). Additionally, patient tolerance to FAF imaging is lower because of the high light intensity used during acquisition.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“On FAF, GA lesions appear as areas of decreased autofluorescence (hypoautofluorescence) due to a lack of lipofuscin as a result of RPE cell atrophy.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Expert panel recommendations: screening examinations and referral
“Among all ECPs, regardless of practice specialty, there was unanimous agreement that there is currently no standardized process by which GA is identified and diagnosed, thus revealing a significant unmet need.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The primary ECP should inquire with the patient about GA symptoms, perform a comprehensive ocular examination that includes best-corrected visual acuity assessment, and conduct a retinal examination and OCT scan to identify any signs of AMD in one or both eyes.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“A nonurgent referral to a retina specialist is recommended for any suspected GA in one or both eyes, whereas a more urgent referral should be made for any patient with suspected neovascular AMD (nAMD)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Delphi consensus on diagnostic imaging
“Consensus was achieved in several topics related to diagnostic imaging, including the use of optical coherence tomography, and the urgent need for treatments and beneficial interventions to reduce the associated burden.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Imaging modalities for detection and limits of visual acuity as a marker
“Because best-corrected VA does not correlate well with GA lesions or progression, alternative clinical endpoints are being sought.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Detection of GA can be achieved with a number of different imaging techniques, including color fundus photography, fluorescein angiography, fundus autofluorescence (FAF), near-infrared reflectance, and spectral-domain optical coherence tomography.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote